Tag: designation

BioXcel Therapeutics NASDAQ BTAI FDA Fast Track Designation Acute Agitation News

BioXcel Therapeutics, Inc. (NASDAQ: BTAI) Soars 91% After Receiving FDA’s Fast Track Designation for BXCL501

by admin

December 27, 2018

BioXcel Therapeutics, Inc. (NASDAQ: BTAI) is a clinical-stage biopharmaceutical company, focused on the development of new treatments for neuroscience and ...

No Result

View All Result

Home
News
Video
Stock and Crypto Screener

Tag: designation

BioXcel Therapeutics, Inc. (NASDAQ: BTAI) Soars 91% After Receiving FDA’s Fast Track Designation for BXCL501

Asure Software (NASDAQ: ASUR) is Expanding to Meet the Rising Demand for Human Capital Management Software

OLB Group (NASDAQ: OLB) and Cuentas (NASDAQ: CUEN) Team Up to Bring Fintech Solutions to Over 32,000 Bodegas Across the United States

New Purchase Orders for SD7 Rugged Device, VK7, and Other Accessories Boost Siyata Mobile’s Outlook (NASDAQ: SYTA)

Telcoin (TEL) Quietly Leads a Crypto Remittance Revolution

Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

Safe-T (NASDAQ: SFET) Has Been Selected to Present at the United Nations’ Office of Information and Communications Technology Event

Safe-T Group (NASDAQ: SFET) Reports Fourth Quarter and Full Year 2020 Financial Results

Safe-T Group Ltd. (NASDAQ: SFET) Estimates Record-High Annual Revenues of Approximately $4.9 Million Representing ~50% Growth YoY 2020

Elys Game Technology Corp (NASDAQ: ELYS) Completes Acquisition of Engage IT Services, a Software Engineering and IT Development Company

Tenax Therapeutics (NASDAQ: TENX) Granted U.S. Patent for IV Levosimendan for Pulmonary Hypertension with Heart Failure and Preserved Ejection Fraction (PH-HFpEF)

Versus Systems (NASDAQ: VS) and Resolve Debt Partner to Integrated Generative AI and Gamification to Customer Payments and Credit Markets

Finding the Most Accurate Technical Analysis Indicator

Recent News

Elys Game Technology Corp (NASDAQ: ELYS) Completes Acquisition of Engage IT Services, a Software Engineering and IT Development Company

Tenax Therapeutics (NASDAQ: TENX) Granted U.S. Patent for IV Levosimendan for Pulmonary Hypertension with Heart Failure and Preserved Ejection Fraction (PH-HFpEF)

Categories

Site Navigation